ST Pharm Reports 6.5 Billion KRW Operating Loss in 1Q, Reduced by 29% YoY
[Asia Economy Reporter Ji Yeon-jin] ST Pharm announced on the 28th that its consolidated sales for the first quarter of this year amounted to 27.257 billion KRW, a 35.2% increase compared to the same period last year.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- One in 77 Koreans Exposed to Drugs... Enough Money for 6,600 Luxury Gangnam Apartments Circulates in Drug Market [ChwiYakGukga] ⑩
- President Lee: "20th Anniversary of the Late Dr. Lee Jong-wook's Passing... Will Contribute to Advancing Global Health"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
During this period, operating loss was 6.508 billion KRW, a 29.6% decrease in loss, while net loss for the period increased by 14.3% to 5.057 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
